The report highlights the extreme brutality of some BLA attacks, citing the hijacking of the Jaffar Express in Balochistan on ...

Step into the world of cutting-edge design with these 15 innovative furniture pieces that redefine style and functionality ...

Gain insights from Ocugen's Q2 2025 earnings call, highlighting clinical advancements, strategic partnerships, BLA milestones for 2026-2027, and ...

Regeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD ...

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive leadership team will host the call, which ...

ISLAMABAD: Pakistan has emphatically stated that there is no change in its policy or stance on Jammu and Kashmir dispute and ...

Voters who have not submitted documentary proof also have a month to do so at special camps at block-cum-circle offices and ...

These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...

Tactical victories cannot eliminate terrorism without addressing the ideological foundations and environments that enable ...

President Trump’s recent decision to impose tariffs and penalties on India indicates a significant strain on the bilateral ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Q2 2025 Earnings Call Transcript July 31, 2025 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...